SEC Form D · filed January 4, 2021
EYEGATE PHARMACEUTICALS INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
John Iadeluca · New York, NYDirectorThomas Hancock · Waltham, MADirectorAccumulus Capital Partners, LLC · New York, NYDirectorKeith Maher · Waltham, MADirectorDaniel Wachtler · Redmond, WADirectorJay Lee · Redmond, WADirectorSteven Boyd · Waltham, MADirectorAmir Nashat · CAMBRIDGE, MADirectorScott Fletcher · Ross, CADirectorSarah Romano · Waltham, MAExecRichard Young · CAMBRIDGE, MAExecJoshua G. Kazam · New York, NYDirectorBrian Mcveigh · Hatfield, PADirectorJustin Jory · Woodbridge, VADirectorJosh Mandel-Brehm · CAMBRIDGE, MAExec · DirectorMorton Goldberg · Waltham, MADirectorStephen From · Waltham, MAExec · DirectorTony Wood · Vancouver, British Columbia, CanadaDirectorBernard Malfroy-Camine · Waltham, MADirectorRodney D. Brown · LEESBURG, VAExec · DirectorPaul Chaney · Waltham, MADirectorTom Bruderman · Redmond, WADirectorSoutheast Asset Advisors, LLC · Thomasville, GADirectorDavid Wurtzbacher · Woodbridge, VAExecPaula Ragan · CAMBRIDGE, MADirectorRandy H. Hopkins · Meridian, IDDirectorPraveen Tyle · Waltham, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗